Φορτώνει......
A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy
Combination immunotherapy has recently emerged as a powerful cancer treatment strategy. A promising treatment approach utilizes coadministration of antagonistic antibodies to block checkpoint inhibitor receptors, such as antiprogrammed cell death-1 (aPD1), alongside agonistic antibodies to activate...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Adv Mater |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003883/ https://ncbi.nlm.nih.gov/pubmed/29691900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adma.201706098 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|